They further researched that miR-155 was a TNF-α-inducible transcript, and the expression levels of SHIP1 and miR-155 were valuable prognostic indicators in DLBCL, so that anti-TNF-α therapy could be used as a novel and immediately accessible (co)treatment for DLBCL [80]. Here, INPP5D is linked to diffuse large B-cell lymphoma.